title: Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation.
authors.affiliation: Department of Bone Marrow Transplantation, Hadassah-Hebrew University Hospital and School of Medicine, Jerusalem, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Slavin
authors.forename: A
authors.initials: A
authors.lastname: Ackerstein
authors.forename: E
authors.initials: E
authors.lastname: Kedar
authors.forename: S
authors.initials: S
authors.lastname: Reich
authors.forename: S
authors.initials: S
authors.lastname: Gomez
authors.forename: E
authors.initials: E
authors.lastname: Naparstek
authors.forename: A
authors.initials: A
authors.lastname: Nagler
authors.forename: R
authors.initials: R
authors.lastname: Or
authors.forename: L
authors.initials: L
authors.lastname: Weiss
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D011994:Recombinant Proteins / Q000627:therapeutic use; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins